- Home
- ZYME vs SBSI Comparison
ZYME vs SBSI Comparison
Compare ZYME & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- SBSI
- Stock Information
- Founded
- ZYME 2003
- SBSI 1960
- Country
- ZYME United States
- SBSI United States
- Employees
- ZYME N/A
- SBSI N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- SBSI Major Banks
- Sector
- ZYME Health Care
- SBSI Finance
- Exchange
- ZYME Nasdaq
- SBSI Nasdaq
- Market Cap
- ZYME 968.5M
- SBSI 920.2M
- IPO Year
- ZYME 2017
- SBSI N/A
- Fundamental
- Price
- ZYME $15.93
- SBSI $30.17
- Analyst Decision
- ZYME Buy
- SBSI Hold
- Analyst Count
- ZYME 7
- SBSI 3
- Target Price
- ZYME $20.00
- SBSI $35.00
- AVG Volume (30 Days)
- ZYME 446.6K
- SBSI 103.2K
- Earning Date
- ZYME 10-30-2025
- SBSI 10-23-2025
- Dividend Yield
- ZYME N/A
- SBSI 4.73%
- EPS Growth
- ZYME N/A
- SBSI 4.30
- EPS
- ZYME N/A
- SBSI 2.81
- Revenue
- ZYME $122,867,000.00
- SBSI $254,956,000.00
- Revenue This Year
- ZYME $107.76
- SBSI $11.17
- Revenue Next Year
- ZYME $2.35
- SBSI $5.65
- P/E Ratio
- ZYME N/A
- SBSI $10.84
- Revenue Growth
- ZYME 95.94
- SBSI 6.01
- 52 Week Low
- ZYME $9.03
- SBSI $25.85
- 52 Week High
- ZYME $17.70
- SBSI $38.00
- Technical
- Relative Strength Index (RSI)
- ZYME 64.90
- SBSI 45.74
- Support Level
- ZYME $14.88
- SBSI $30.30
- Resistance Level
- ZYME $16.37
- SBSI $30.81
- Average True Range (ATR)
- ZYME 0.65
- SBSI 0.50
- MACD
- ZYME 0.11
- SBSI -0.11
- Stochastic Oscillator
- ZYME 84.12
- SBSI 3.57
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.